A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer

BACKGROUND: Bladder cancer (BLCA) represents a highly heterogeneous disease characterized by distinct histological, molecular, and clinical features, whose tumorigenesis and progression require aberrant metabolic reprogramming of tumor cells. However, current studies have not expounded systematicall...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yun, Cheng, Yifei, Wang, Ziyu, Li, Lu, Qian, Zhengtao, Xia, Wei, Yu, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403905/
https://www.ncbi.nlm.nih.gov/pubmed/37543645
http://dx.doi.org/10.1186/s12885-023-11182-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403905/
https://www.ncbi.nlm.nih.gov/pubmed/37543645
http://dx.doi.org/10.1186/s12885-023-11182-w

Ejemplares similares